Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02860546
Title A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field